LFG
PRTK

Larson Financial Group’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Larson Financial Group’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2
Closed – – 864
2020
Q2 		$0 Hold
2
– – ﹤0.01% 781
2020
Q1 		$0 Hold
2
– – ﹤0.01% 683
2019
Q4 		$0 Hold
2
– – ﹤0.01% 679
2019
Q3 		$0 Hold
2
– – ﹤0.01% 637
2019
Q2 		$0 Hold
2
– – ﹤0.01% 584
2019
Q1 		$0 Buy
+2
New +$13 ﹤0.01% 556

Other funds holding PRTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Larson Financial Group's PRTK Position: Q3 2020 in Review

Larson Financial Group sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2020, closing a stake of 2 shares.

Larson Financial Group first reported a position in PRTK in Q1 2019 and held it in 6 quarters. The position peaked at $0 in Q2 2020. 100 funds tracked by Wall St. Rank hold PRTK as of Q3 2020.

  • Larson Financial Group reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Larson Financial Group sold 2 Paratek Pharmaceuticals, Inc. shares in Q3 2020.
  • Larson Financial Group first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2019 and held it in 6 quarters.
  • Larson Financial Group's Paratek Pharmaceuticals, Inc. position peaked at $0 in Q2 2020.
  • 100 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2020.

Based on Larson Financial Group's 13F filing for Q3 2020, filed 8 Oct 2020.